Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | ||
|---|---|---|---|---|---|
| 1 | 2 | 3 | |||
| Bronchospasm | x | x | x | ||
| Confusional state | x | x | x | ||
| Constipation | x | x | x | ||
| Dizziness | x | x | x | ||
| Headache | x | x | x | ||
| Hypersensitivity | x | x | x | ||
| Laryngospasm | x | x | x | ||
| Nasal congestion | x | x | x | ||
| Nausea | x | x | x | ||
| Numbness | x | x | x | ||
| Pruritus | x | x | x | ||
| Convulsion | x | ||||
| Shock | x | x | x | ||
| Tremor | x | ||||
| Agitation | x | ||||
| CNS depression NOS | x | ||||
| Hallucination, visual | x | x | x | ||
| Clonic convulsion | x | ||||
| Eruption | x | x | x | ||
| Gastrointestinal tract irritation | x | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||
|---|---|---|---|---|---|
| Cough | x | x | x | ||
| Intoxication | x | ||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |